Does Acyclovir Cause Kidney Damage?
Acyclovir, an antiviral used for herpes infections, can harm kidneys, especially with long-term or high-dose use. It crystallizes in renal tubules when poorly soluble, blocking urine flow and causing acute kidney injury (AKI). This risk rises in dehydrated patients or those with pre-existing kidney issues.[1][2]
How Does Acyclovir Damage Kidneys Exactly?
The drug precipitates in tubules at high concentrations, leading to obstruction, inflammation, and reduced glomerular filtration rate (GFR). Intravenous forms pose higher risk than oral due to peak blood levels. Studies show AKI in 12-48% of high-risk IV recipients, often reversible if caught early.[3][4]
What Raises the Risk of Long-Term Kidney Problems?
- Dehydration or low urine output.
- High doses (>500 mg/m² IV) or prolonged therapy.
- Pre-existing chronic kidney disease (CKD).
- Concurrent nephrotoxins like aminoglycosides.
- Older age or conditions like diabetes. Long-term oral use (e.g., suppression therapy) rarely causes issues but monitoring is advised for at-risk patients.[1][5]
Can Kidney Damage from Acyclovir Become Permanent?
Most cases resolve within weeks after stopping the drug and hydrating aggressively, with GFR recovering fully in 70-90% of patients. Chronic damage occurs if repeated exposures or delayed treatment lead to fibrosis or progression to CKD. One study tracked 20 patients post-AKI; 15% had persistent GFR decline after 6 months.[4][6]
How Do Doctors Prevent and Monitor Kidney Issues?
Hydrate patients (2-3 L/day fluids) before and during IV therapy. Check serum creatinine and urine output daily. Dose-adjust for GFR <50 mL/min (e.g., halve dose at GFR 25-50). Switch to oral valacyclovir if possible for maintenance. Routine monitoring every 3-6 months for long-term users with risk factors.[2][7]
What Symptoms Signal Kidney Trouble?
Watch for reduced urine, flank pain, nausea, rising creatinine, or crystal detection in urine microscopy. Early signs appear 24-48 hours into IV treatment.[1]
Alternatives for Patients Worried About Kidneys
Valacyclovir or famciclovir have better solubility and lower nephrotoxicity for oral therapy. For severe cases, foscarnet may substitute but carries its own risks. Kidney transplant patients often avoid acyclovir prophylaxis.[5][8]
Sources
[1] FDA Acyclovir Label
[2] NEJM: Acyclovir Nephrotoxicity
[3] Clinical Infectious Diseases Review
[4] American Journal of Kidney Diseases Study
[5] UpToDate: Acyclovir Overview
[6] Kidney International Case Series
[7] ASHP Guidelines
[8] Drugs.com Comparison